Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 4/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | ABL1 | P00519 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.32 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 10/20 | 0.31 |
| ▸ | MMP3 | P08254 | 8/20 | 0.31 |
| ▸ | MMP1 | P03956 | 7/20 | 0.31 |
| ▸ | MMP7 | P09237 | 6/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8202225 | 0.83 | CNR1 (0.37) | CNR2CNR1GPR55 | |
| SCHEMBL8893624 | 0.83 | CNR1 (0.33) | L3MBTL1CNR2CNR1GPR55GPR18 | |
| SCHEMBL6201326 | 0.82 | L3MBTL1 (0.37) | L3MBTL1CNR2HDAC11HDAC8ABL1 | |
| SCHEMBL8200735 | 0.79 | L3MBTL1 (0.37) | L3MBTL1CNR2HDAC11HDAC8ABL1 | |
| SCHEMBL8193843 | 0.67 | MMP1 (0.34) | CNR2CNR1GPR55GPR18MMP1 | |
| SCHEMBL8892569 | 0.65 | L3MBTL1 (0.33) | L3MBTL1CNR2CNR1GPR55GPR18 | |
| SCHEMBL9279589 | 0.65 | LMNA (0.39) | L3MBTL1 | |
| SCHEMBL6201097 | 0.64 | CNR1 (0.38) | CNR2CNR1GPR55 | |
| SCHEMBL6716613 | 0.64 | L3MBTL1 (0.47) | L3MBTL1MMP1SIGMAR1 | |
| SCHEMBL6201198 | 0.62 | AR (0.36) | L3MBTL1CNR2CNR1GPR55GPR18 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0971744-A2 | COMBINATION THERAPY EMPLOYING ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998040375-A2 | COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS | G.D. SEARLE & CO. (US) | 1998-09-17 | — | — | WO | disclosed |